Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
69
IBCP Quote, Financials, Valuation and Earnings
Last price:
$34.36
Seasonality move
:
3.01%
Day range:
$33.55 - $34.54
52-week range:
$26.75 - $40.32
Dividend yield:
2.91%
P/E ratio:
10.94x
P/S ratio:
3.34x
P/B ratio:
1.52x
Volume:
72.6K
Avg. volume:
79.3K
1-year change:
8.45%
Market cap:
$712M
Revenue:
$215.8M
EPS (TTM):
$3.14
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $198M | $198.8M | $204.8M | $200.5M | $215.8M | |
| Revenue Growth (YoY) | 20.41% | 0.42% | 3.01% | -2.1% | 7.64% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $81.8M | $83.3M | $86.1M | $85.1M | $91.8M | |
| Other Inc / (Exp) | $267K | $1.4M | -$275K | -$222K | $2.3M | |
| Operating Expenses | $81.8M | $83.3M | $86.9M | $85.6M | $92.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $69.5M | $77.3M | $77.8M | $73.7M | $83M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.3M | $14.4M | $14.4M | $14.6M | $16.3M | |
| Net Income to Company | $56.2M | $62.9M | $63.4M | $59.1M | $66.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $56.2M | $62.9M | $63.4M | $59.1M | $66.8M | |
| Basic EPS (Cont. Ops) | $2.56 | $2.91 | $3.00 | $2.82 | $3.20 | |
| Diluted EPS (Cont. Ops) | $2.53 | $2.88 | $2.97 | $2.79 | $3.16 | |
| Weighted Average Basic Share | $22M | $21.6M | $21.1M | $21M | $20.9M | |
| Weighted Average Diluted Share | $22.2M | $21.8M | $21.3M | $21.2M | $21.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $85.7M | $85.6M | $97.2M | $157M | $183.6M | |
| Revenue (Reported) | $198M | $198.8M | $204.8M | $200.5M | $215.8M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $85.7M | $85.6M | $97.2M | $157M | $183.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $55.2M | $50.4M | $47.3M | $51.2M | $52.3M | |
| Revenue Growth (YoY) | 40.71% | -8.67% | -6.02% | 8.19% | 2.04% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.6M | $21.3M | $20.6M | $22.3M | $22.2M | |
| Other Inc / (Exp) | $1.4M | $70K | -$222K | -$269K | -$330K | |
| Operating Expenses | $22.6M | $21.3M | $20.8M | $22.4M | $22.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $27.1M | $22.1M | $15.9M | $19.8M | $19.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.1M | $4.1M | $2.9M | $3.8M | $3.5M | |
| Net Income to Company | $22M | $18M | $13M | $16M | $15.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $22M | $18M | $13M | $16M | $15.6M | |
| Basic EPS (Cont. Ops) | $1.01 | $0.85 | $0.62 | $0.77 | $0.74 | |
| Diluted EPS (Cont. Ops) | $1.00 | $0.84 | $0.61 | $0.76 | $0.74 | |
| Weighted Average Basic Share | $21.8M | $21.2M | $21.1M | $20.9M | $20.9M | |
| Weighted Average Diluted Share | $22.1M | $21.4M | $21.3M | $21.1M | $21.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $29.4M | $23.8M | $31.4M | $44.8M | $41.6M | |
| Revenue (Reported) | $55.2M | $50.4M | $47.3M | $51.2M | $52.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $29.4M | $23.8M | $31.4M | $44.8M | $41.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $213.4M | $194.2M | $201.8M | $204.2M | $217M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $83.7M | $82M | $85.4M | $86.7M | $92M | |
| Other Inc / (Exp) | $1M | $65K | -$567K | -$269K | $2.2M | |
| Operating Expenses | $83.5M | $82M | $85.5M | $87M | $92.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $90.9M | $72.2M | $71.6M | $77.6M | $82.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.5M | $13.4M | $13.2M | $15.6M | $16M | |
| Net Income to Company | $73.4M | $58.8M | $58.4M | $62.1M | $66.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $73.4M | $58.8M | $58.4M | $62.1M | $66.4M | |
| Basic EPS (Cont. Ops) | $3.36 | $2.75 | $2.78 | $2.97 | $3.17 | |
| Diluted EPS (Cont. Ops) | $3.33 | $2.71 | $2.74 | $2.94 | $3.14 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $103.9M | $80.1M | $104.8M | $170.4M | $180.4M | |
| Revenue (Reported) | $213.4M | $194.2M | $201.8M | $204.2M | $217M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $103.9M | $80.1M | $104.8M | $170.4M | $180.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $55.2M | $50.4M | $47.3M | $51.2M | $52.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $22.6M | $21.3M | $20.6M | $22.3M | $22.2M | |
| Other Inc / (Exp) | $1.4M | $70K | -$222K | -$269K | -$330K | |
| Operating Expenses | $22.6M | $21.3M | $20.8M | $22.4M | $22.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $27.1M | $22.1M | $15.9M | $19.8M | $19.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $5.1M | $4.1M | $2.9M | $3.8M | $3.5M | |
| Net Income to Company | $22M | $18M | $13M | $16M | $15.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $22M | $18M | $13M | $16M | $15.6M | |
| Basic EPS (Cont. Ops) | $1.01 | $0.85 | $0.62 | $0.77 | $0.74 | |
| Diluted EPS (Cont. Ops) | $1.00 | $0.84 | $0.61 | $0.76 | $0.74 | |
| Weighted Average Basic Share | $21.8M | $21.2M | $21.1M | $20.9M | $20.9M | |
| Weighted Average Diluted Share | $22.1M | $21.4M | $21.3M | $21.1M | $21.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $29.4M | $23.8M | $31.4M | $44.8M | $41.6M | |
| Revenue (Reported) | $55.2M | $50.4M | $47.3M | $51.2M | $52.3M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $29.4M | $23.8M | $31.4M | $44.8M | $41.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $118.7M | $109.5M | $74.4M | $169.8M | $119.9M | |
| Short Term Investments | $1.1B | $1.4B | $779.3M | $679.4M | $25.4M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.2B | $1.5B | $853.7M | $849.1M | $145.3M | |
| Property Plant And Equipment | $36.1M | $36.4M | $35.9M | $35.5M | $37.5M | |
| Long-Term Investments | $1.1B | $1.4B | $1.2B | $1B | $898.6M | |
| Goodwill | $28.3M | $28.3M | $28.3M | $28.3M | $28.3M | |
| Other Intangibles | $21.2M | $29.6M | $45M | $44.2M | $48.3M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.2B | $4.7B | $5B | $5.3B | $5.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $108.8M | $109M | $165.1M | $129.3M | $124.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.8B | $4.3B | $4.7B | $4.9B | $4.9B | |
| Common Stock | $339.4M | $323.4M | $321M | $317.5M | $318.8M | |
| Other Common Equity Adj | $10M | $501K | -$92.8M | -$72.1M | -$69.9M | |
| Common Equity | $389.5M | $398.5M | $347.6M | $404.4M | $454.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $389.5M | $398.5M | $347.6M | $404.4M | $454.7M | |
| Total Liabilities and Equity | $4.2B | $4.7B | $5B | $5.3B | $5.3B | |
| Cash and Short Terms | $1.2B | $1.5B | $853.7M | $849.1M | $145.3M | |
| Total Debt | $108.8M | $109M | $165.1M | $129.3M | $124.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $130.5M | $109.8M | $227M | $161.8M | $128.1M | |
| Short Term Investments | $1.2B | $1.4B | $767.5M | $613.6M | $529.7M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.4B | $1.5B | $994.5M | $775.5M | $657.8M | |
| Property Plant And Equipment | $36.7M | $37.4M | $35.8M | $34.6M | $37.4M | |
| Long-Term Investments | $1.2B | $1.4B | $1.1B | $963.6M | $866.6M | |
| Goodwill | $28.3M | $28.3M | $28.3M | $28.3M | $28.3M | |
| Other Intangibles | $27.6M | $39M | $44.3M | $45.5M | $33.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $4.4B | $4.8B | $5.1B | $5.2B | $5.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | -- | |
| Long-Term Debt | $108.8M | $109M | $129.2M | $129.3M | $124.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4B | $4.4B | $4.8B | $4.8B | $4.9B | |
| Common Stock | $335.7M | $322M | $321M | $317.1M | $318.4M | |
| Other Common Equity Adj | $4.3M | -$54.4M | -$80.8M | -$71.6M | -$67.1M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $387.3M | $355.4M | $367.7M | $415.6M | $467.3M | |
| Total Liabilities and Equity | $4.4B | $4.8B | $5.1B | $5.2B | $5.3B | |
| Cash and Short Terms | $1.4B | $1.5B | $994.5M | $775.5M | $657.8M | |
| Total Debt | $108.8M | $109M | $129.2M | $129.3M | $124.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $56.2M | $62.9M | $63.4M | $59.1M | $66.8M | |
| Depreciation & Amoritzation | $9.2M | $12.1M | $10.8M | $10M | $10M | |
| Stock-Based Compensation | $2M | $1.9M | $2.1M | $2.2M | $2.3M | |
| Change in Accounts Receivable | -$8M | -$11.7M | -$25.8M | -$14.6M | -$25.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $58.7M | $110.2M | $94.6M | $75.6M | $63.2M | |
| Capital Expenditures | $4.4M | $5.8M | $5.7M | $6M | $8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$553.9M | -$563.1M | -$424.6M | -$162.9M | -$118.2M | |
| Dividends Paid (Ex Special Dividend) | -$17.6M | -$18.2M | -$18.6M | -$19.3M | -$20M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $278.5M | $100M | $351M | $135M | $130M | |
| Long-Term Debt Repaid | -$297.9M | -$100M | -$295M | -$171M | -$135M | |
| Repurchase of Common Stock | -$14.2M | -$17.3M | -$4M | -$5.2M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $548.6M | $443.7M | $294.9M | $182.8M | $5.1M | |
| Beginning Cash (CF) | $65.3M | $118.7M | $109.5M | $74.4M | $169.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $53.4M | -$9.2M | -$35.1M | $95.4M | -$49.9M | |
| Ending Cash (CF) | $118.7M | $109.5M | $74.4M | $169.8M | $119.9M | |
| Levered Free Cash Flow | $54.3M | $104.3M | $89M | $69.6M | $55.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $22M | $18M | $13M | $16M | $15.6M | |
| Depreciation & Amoritzation | $3.2M | $2.9M | $2.4M | $2.5M | $2.4M | |
| Stock-Based Compensation | $442K | $511K | $569K | $591K | $758K | |
| Change in Accounts Receivable | -$8.5M | -$7M | $1.8M | -$3.3M | $16.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $35.1M | $38.6M | $23.4M | $20.8M | $31.7M | |
| Capital Expenditures | $1.9M | $2.4M | $1.3M | $676K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$235.8M | -$120M | $5M | $17.7M | $3.3M | |
| Dividends Paid (Ex Special Dividend) | -$4.6M | -$4.7M | -$4.9M | -$5M | -$5.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $95M | -- | $95M | |
| Long-Term Debt Repaid | -$6K | -$3K | -$131M | -$22K | -$95M | |
| Repurchase of Common Stock | -$3.6M | -$1.4M | -- | -- | -$33K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $212.5M | $81.8M | $124.3M | -$46.5M | -$26.8M | |
| Beginning Cash (CF) | $118.7M | $109.5M | $74.4M | $169.8M | $119.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.8M | $348K | $152.6M | -$7.9M | $8.3M | |
| Ending Cash (CF) | $130.5M | $109.8M | $227M | $161.8M | $128.1M | |
| Levered Free Cash Flow | $33.1M | $36.2M | $22.1M | $20.2M | $30.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $73.4M | $58.8M | $58.4M | $62.1M | $66.4M | |
| Depreciation & Amoritzation | $10.5M | $11.8M | $10.4M | $10.1M | $9.8M | |
| Stock-Based Compensation | $1.9M | $2M | $2.2M | $2.3M | $2.5M | |
| Change in Accounts Receivable | -$21.5M | -$10.2M | -$17.1M | -$19.7M | -$5.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $71.5M | $113.7M | $79.4M | $73M | $74M | |
| Capital Expenditures | $5.6M | $6.3M | $4.6M | $5.4M | $8.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$731.1M | -$447.3M | -$299.6M | -$150.2M | -$132.5M | |
| Dividends Paid (Ex Special Dividend) | -$17.7M | -$18.2M | -$18.8M | -$19.5M | -$20.5M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $100M | $446M | $40M | $225M | |
| Long-Term Debt Repaid | -$144.9M | -$100M | -$426M | -$40M | -$230M | |
| Repurchase of Common Stock | -$4M | -$15.1M | -- | -$5.2M | -$33K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $719.9M | $313M | $337.4M | $12M | $24.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $60.2M | -$20.7M | $117.2M | -$65.2M | -$33.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $65.9M | $107.4M | $74.8M | $67.7M | $65.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $22M | $18M | $13M | $16M | $15.6M | |
| Depreciation & Amoritzation | $3.2M | $2.9M | $2.4M | $2.5M | $2.4M | |
| Stock-Based Compensation | $442K | $511K | $569K | $591K | $758K | |
| Change in Accounts Receivable | -$8.5M | -$7M | $1.8M | -$3.3M | $16.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $35.1M | $38.6M | $23.4M | $20.8M | $31.7M | |
| Capital Expenditures | $1.9M | $2.4M | $1.3M | $676K | $1.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$235.8M | -$120M | $5M | $17.7M | $3.3M | |
| Dividends Paid (Ex Special Dividend) | -$4.6M | -$4.7M | -$4.9M | -$5M | -$5.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $95M | -- | $95M | |
| Long-Term Debt Repaid | -$6K | -$3K | -$131M | -$22K | -$95M | |
| Repurchase of Common Stock | -$3.6M | -$1.4M | -- | -- | -$33K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $212.5M | $81.8M | $124.3M | -$46.5M | -$26.8M | |
| Beginning Cash (CF) | $118.7M | $109.5M | $74.4M | $169.8M | $119.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.8M | $348K | $152.6M | -$7.9M | $8.3M | |
| Ending Cash (CF) | $130.5M | $109.8M | $227M | $161.8M | $128.1M | |
| Levered Free Cash Flow | $33.1M | $36.2M | $22.1M | $20.2M | $30.6M | |
Get IBCP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
IBCP
Sector
P/E ratio
10.94x
12.21x
PEG ratio
1.61x
0.40x
P/B ratio
1.52x
1.11x
Price / LTM sales
3.34x
2.66x
Growth Metrics
IBCP
Sector
Revenue growth
2.04%
5.12%
Earnings growth
-2.63%
2.63%
Revenue (5-year growth)
5.59%
5.17%
Earnings forecast
$0.79
$0.61
Profitability
IBCP
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
11.83%
5.21%
Return on assets
1.26%
0.97%
Return on equity
14.95%
9.24%
Earnings Date
Last Earnings Date
Apr
24
Next Earnings Date
Jul
24
Estimated Next Earnings Date
Jul
24
Balance Sheet
IBCP
Sector
Total cash
$657.8M
$451.2M
Short term investments
$25.4M
$220.9M
Total assets
$5.3B
$3.8B
Long term debt
$124.4M
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
